Sumitomo Pharma Co Ltd
TSE:4506
Sumitomo Pharma Co Ltd
TSE:4506
Price:
339 JPY
0.89%
Market Closed
Updated:
May 21, 2024
Sumitomo Pharma Co Ltd
Research & Development
|
Sumitomo Pharma Co Ltd
Research & Development Peer Comparison
Comparables:
4502
4568
4578
4519
4503
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sumitomo Pharma Co Ltd
TSE:4506
|
Research & Development
-¥129.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-7%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Research & Development
-¥729.9B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-8%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Research & Development
-¥365.2B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-28%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Research & Development
-¥312.2B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-2%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Research & Development
-¥172.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-9%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Research & Development
-¥294.2B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-4%
|
See Also
What is Sumitomo Pharma Co Ltd's Research & Development?
Research & Development
-129.5B
JPY
-129.5B
JPY
Based on the financial report for Dec 31, 2023, Sumitomo Pharma Co Ltd's Research & Development amounts to -129.5B JPY.
What is Sumitomo Pharma Co Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-7%
-7%
Over the last year, the Research & Development growth was -26%.
You don't have any saved screeners yet
